Submission for OMB Review; 30-Day Comment Request National Institutes of Health (NIH) Loan Repayment Programs; Office of the Director (OD), 44642-44643 [2016-16227]
Download as PDF
<![CDATA[
44642
Federal Register / Vol. 81, No. 131 / Friday, July 8, 2016 / Notices
III. Response to Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble.
Dated: June 29, 2016.
Kathryn E. Martin,
Acting Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2016–16067 Filed 7–6–16; 8:45 am]
BILLING CODE 4150–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: July 1, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
National Institutes of Health
Public Workshop—Iron Screening and
Supplementation of Iron-Replete
Pregnant Women and Young Children
The Office of Dietary
Supplements at the National Institutes
of Health (NIH) is sponsoring an open
public workshop titled, ‘‘Iron Screening
and Supplementation of Iron-replete
Pregnant Women and Young Children,’’
September 28–29, 2016, on the NIH
main campus in Bethesda, Maryland. It
will also be available to be viewed live
or later on-demand as a videocast. The
workshop discussions will focus on the
U.S. and developed countries and will
serve to specify data gaps and research
needs by (1) exploring current
understanding of iron homeostasis in
pregnant women and in young children
(6-24 months); (2) identifying the
challenges associated with measuring
iron status and with screening practices;
and (3) considering emerging issues
associated with routine
supplementation of iron-replete
individuals. All persons are invited to
attend, especially clinical educators,
those who develop clinical
recommendations, health care providers
and researchers. Persons wishing to
attend are required to register in
advance of the conference.
DATES: September 28–29, 2016; 8:30 to
5:15 p.m. (Eastern Time) on the first day
and 8:00 to 12:30 p.m. on the second
day.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
National Institutes of
Health, William H. Natcher Building;
Natcher Conference Center, Building 45,
Bethesda, Maryland, 20892.
FOR FURTHER INFORMATION CONTACT: Ms.
Cindy Rooney, Office of Dietary
Supplements, National Institutes of
Health, 6100 Executive Boulevard,
ADDRESSES:
VerDate Sep<11>2014
17:00 Jul 07, 2016
Jkt 238001
Room 3B01, Bethesda, MD 20892–7523,
Email: rooneyc@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The
conference is sponsored by the NIH
Office of Dietary Supplements along
with co-sponsors from other federal
agencies. Information about the
conference agenda, registration
procedures, and videocast arrangements
can be found at: https://eventssuport.com/events/NIH_Iron_Workshop.
Through its Iron Initiative, the
National Institutes of Health (NIH)
Office of Dietary Supplements leads
efforts to advance scientific
understanding of iron and health:
https://ods.od.nih.gov/Research/
Iron.aspx.
[FR Doc. 2016–16254 Filed 7–7–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request National Institutes
of Health (NIH) Loan Repayment
Programs; Office of the Director (OD)
Under the provisions of
section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Division of
Loan Repayment (DLR), the National
Institutes of Health (NIH), has submitted
to the Office of Management and Budget
(OMB) a request to review and approve
the information collection listed below.
This proposed information collection
was previously published in the Federal
Register on February 19, 2016, and page
numbers 8514–8516, and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The NIH
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
SUMMARY:
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project
contact: Steve Boehlert, Director of
Operations, Division of Loan
Repayment, National Institutes of
Health, 6011 Executive Blvd., Room 206
(MSC 7650), Bethesda, Maryland
20892–7650. Mr. Boehlert may be
contacted via email at BoehlerS@
od.nih.gov or by calling 301–451–4465.
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: National
Institutes of Health (NIH) Loan
Repayment Programs (LRP). Type of
Information Collection Request:
Revision of a currently approved
collection (OMB No. 0925–0361,
expiration date 06/30/17). Form
Numbers: NIH 2674–1, NIH 2674–2,
NIH 2674–3, NIH 2674–4, NIH 2674–5,
NIH 2674–6, NIH 2674–7, NIH 2674–8,
NIH 2674–9, NIH 2674–10, NIH 2674–
11, NIH 2674–12, NIH 2674–13, NIH
2674–14, NIH 2674–15, NIH 2674–16,
NIH 2674–17, NIH 2674–18, NIH 2674–
19, and NIH 2674–20 (new).
Need and Use of Information
Collection: The NIH makes available
financial assistance, in the form of
educational loan repayment, to M.D.,
Ph.D., Pharm.D., Psy.D., D.O., D.D.S.,
D.M.D., D.P.M., D.C., N.D., O.D., D.V.M.,
or equivalent degree holders who
perform biomedical or behavioral
research in NIH intramural laboratories
or as extramural grantees or scientists
funded by domestic non-profit
organizations for a minimum of two
years (three years for the General
Research LRP) in research areas
supporting the mission and priorities of
the NIH.
The AIDS Research Loan Repayment
Program (AIDS–LRP) is authorized by
section 487A of the Public Health
Service Act (42 U.S.C. 288–1); the
Clinical Research Loan Repayment
Program for Individuals from
Disadvantaged Backgrounds (CR–LRP)
is authorized by section 487E (42 U.S.C.
288–5); the General Research Loan
Repayment Program (GR–LRP) is
authorized by section 487C of the Public
Health Service Act (42 U.S.C. 288–3);
the Clinical Research Loan Repayment
Program (LRP–CR) is authorized by
section 487F (42 U.S.C. 288–5a); the
Pediatric Research Loan Repayment
Program (PR–LRP) is authorized by
E:\FR\FM\08JYN1.SGM
08JYN1
44643
Federal Register / Vol. 81, No. 131 / Friday, July 8, 2016 / Notices
section 487F (42 U.S.C. 288–6); the
Extramural Clinical Research LRP for
Individuals from Disadvantaged
Backgrounds (ECR–LRP) is authorized
by an amendment to section 487E (42
U.S.C. 288–5); the Contraception and
Infertility Research LRP (CIR–LRP) is
authorized by section 487B (42 U.S.C.
288–2); and the Health Disparities
Research Loan Repayment Program
(HD–LRP) is authorized by section 485G
(42 U.S.C. 287c–33).
The Loan Repayment Programs can
repay up to $35,000 per year toward a
participant’s extant eligible educational
loans, directly to financial institutions.
The information proposed for collection
better user experience. Recommenders
will no longer be asked to complete a
recommendation form, but to write a
reference letter that comments on the
research skills and the abilities of the
applicant. A general eligibility checklist
(NIH 2674–20) was added at the start of
the application to reduce the likelihood
of ineligible individuals working
through the application only to learn of
their disqualification after submitting
the application. Redundant questions or
statements were eliminated. OMB
approval is requested for 3 years. There
are no costs to respondents other than
their time. The total estimated
annualized burden hours are 33,242.
will be used by the Division of Loan
Repayment to determine an applicant’s
eligibility for participation in the
program.
Frequency of Response: Initial
application and one- or two-year
renewal application.
Affected Public: Individuals or
households; Nonprofits; and Businesses
or other for-profit.
Type of Respondents: Physicians,
other scientific or medical personnel,
and institutional representatives.
Questions, required information, and
requested documents remain largely
unchanged. Improvements were made to
the structure and appearance of online
forms to provide applicants with a
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Intramural LRPs
Initial Applicants ...............................................................................................
Advisors/Supervisors .......................................................................................
Recommenders ................................................................................................
Financial Institutions ........................................................................................
Estimated
number of
responses per
respondent
Average
burden
hours per
response
Annual burden
hours
requested
40
40
120
8
1
1
1
1
10
1
30/60
15/60
400
40
60
2
208
........................
........................
502
1,650
1,480
4,950
100
1
1
1
1
11
1
30/60
15/60
18,150
1,480
2,475
25
Subtotal .....................................................................................................
Intramural LRPs
Renewal Applicants .........................................................................................
Advisors/Supervisors .......................................................................................
Subtotal .....................................................................................................
Extramural LRPS
Renewal Applicants .........................................................................................
Advisors/Supervisors .......................................................................................
Recommenders ................................................................................................
8,180
........................
........................
22,130
40
40
80
1
1
........................
7
2
........................
280
80
360
1,000
750
3,000
1
1
1
8
1
30/60
8,000
750
1,500
Subtotal .....................................................................................................
Total ...................................................................................................
4,750
13,218
........................
........................
........................
........................
10,250
33,242
Subtotal .....................................................................................................
Extramural LRPs
Initial Applicants ...............................................................................................
Advisors/Supervisors .......................................................................................
Recommenders ................................................................................................
Financial Institutions ........................................................................................
Dated: July 1, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2016–16227 Filed 7–7–16; 8:45 am]
BILLING CODE 4140–01–P
asabaliauskas on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases: Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
17:00 Jul 07, 2016
Jkt 238001
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, NIDDK Training
Grants Review.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Date: July 26, 2016.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: CAROL J. GOTERROBINSON, PH.D., SCIENTIFIC REVIEW
OFFICER, REVIEW BRANCH, DEA, NIDDK,
NATIONAL INSTITUTES OF HEALTH,
ROOM 7347, 6707 DEMOCRACY
BOULEVARD, BETHESDA, MD 20892–5452,
(301) 594–7791, goterrobinsonc@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Program Project on
Gut Microbial Host Interactions.
Date: August 5, 2016.
E:\FR\FM\08JYN1.SGM
08JYN1
]]>Agencies
[Federal Register Volume 81, Number 131 (Friday, July 8, 2016)]
[Notices]
[Pages 44642-44643]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-16227]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request National
Institutes of Health (NIH) Loan Repayment Programs; Office of the
Director (OD)
SUMMARY: Under the provisions of section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Division of Loan Repayment (DLR), the
National Institutes of Health (NIH), has submitted to the Office of
Management and Budget (OMB) a request to review and approve the
information collection listed below. This proposed information
collection was previously published in the Federal Register on February
19, 2016, and page numbers 8514-8516, and allowed 60 days for public
comment. No public comments were received. The purpose of this notice
is to allow an additional 30 days for public comment. The NIH may not
conduct or sponsor, and the respondent is not required to respond to,
an information collection that has been extended, revised, or
implemented on or after October 1, 1995, unless it displays a currently
valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments or request more information on the
proposed project contact: Steve Boehlert, Director of Operations,
Division of Loan Repayment, National Institutes of Health, 6011
Executive Blvd., Room 206 (MSC 7650), Bethesda, Maryland 20892-7650.
Mr. Boehlert may be contacted via email at BoehlerS@od.nih.gov or by
calling 301-451-4465. Formal requests for additional plans and
instruments must be requested in writing.
Proposed Collection: National Institutes of Health (NIH) Loan
Repayment Programs (LRP). Type of Information Collection Request:
Revision of a currently approved collection (OMB No. 0925-0361,
expiration date 06/30/17). Form Numbers: NIH 2674-1, NIH 2674-2, NIH
2674-3, NIH 2674-4, NIH 2674-5, NIH 2674-6, NIH 2674-7, NIH 2674-8, NIH
2674-9, NIH 2674-10, NIH 2674-11, NIH 2674-12, NIH 2674-13, NIH 2674-
14, NIH 2674-15, NIH 2674-16, NIH 2674-17, NIH 2674-18, NIH 2674-19,
and NIH 2674-20 (new).
Need and Use of Information Collection: The NIH makes available
financial assistance, in the form of educational loan repayment, to
M.D., Ph.D., Pharm.D., Psy.D., D.O., D.D.S., D.M.D., D.P.M., D.C.,
N.D., O.D., D.V.M., or equivalent degree holders who perform biomedical
or behavioral research in NIH intramural laboratories or as extramural
grantees or scientists funded by domestic non-profit organizations for
a minimum of two years (three years for the General Research LRP) in
research areas supporting the mission and priorities of the NIH.
The AIDS Research Loan Repayment Program (AIDS-LRP) is authorized
by section 487A of the Public Health Service Act (42 U.S.C. 288-1); the
Clinical Research Loan Repayment Program for Individuals from
Disadvantaged Backgrounds (CR-LRP) is authorized by section 487E (42
U.S.C. 288-5); the General Research Loan Repayment Program (GR-LRP) is
authorized by section 487C of the Public Health Service Act (42 U.S.C.
288-3); the Clinical Research Loan Repayment Program (LRP-CR) is
authorized by section 487F (42 U.S.C. 288-5a); the Pediatric Research
Loan Repayment Program (PR-LRP) is authorized by
[[Page 44643]]
section 487F (42 U.S.C. 288-6); the Extramural Clinical Research LRP
for Individuals from Disadvantaged Backgrounds (ECR-LRP) is authorized
by an amendment to section 487E (42 U.S.C. 288-5); the Contraception
and Infertility Research LRP (CIR-LRP) is authorized by section 487B
(42 U.S.C. 288-2); and the Health Disparities Research Loan Repayment
Program (HD-LRP) is authorized by section 485G (42 U.S.C. 287c-33).
The Loan Repayment Programs can repay up to $35,000 per year toward
a participant's extant eligible educational loans, directly to
financial institutions. The information proposed for collection will be
used by the Division of Loan Repayment to determine an applicant's
eligibility for participation in the program.
Frequency of Response: Initial application and one- or two-year
renewal application.
Affected Public: Individuals or households; Nonprofits; and
Businesses or other for-profit.
Type of Respondents: Physicians, other scientific or medical
personnel, and institutional representatives.
Questions, required information, and requested documents remain
largely unchanged. Improvements were made to the structure and
appearance of online forms to provide applicants with a better user
experience. Recommenders will no longer be asked to complete a
recommendation form, but to write a reference letter that comments on
the research skills and the abilities of the applicant. A general
eligibility checklist (NIH 2674-20) was added at the start of the
application to reduce the likelihood of ineligible individuals working
through the application only to learn of their disqualification after
submitting the application. Redundant questions or statements were
eliminated. OMB approval is requested for 3 years. There are no costs
to respondents other than their time. The total estimated annualized
burden hours are 33,242.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Estimated
Number of number of Average Annual burden
Type of respondent respondents responses per burden hours hours
respondent per response requested
----------------------------------------------------------------------------------------------------------------
Intramural LRPs
Initial Applicants.............................. 40 1 10 400
Advisors/Supervisors............................ 40 1 1 40
Recommenders.................................... 120 1 30/60 60
Financial Institutions.......................... 8 1 15/60 2
---------------------------------------------------------------
Subtotal.................................... 208 .............. .............. 502
Extramural LRPs
Initial Applicants.............................. 1,650 1 11 18,150
Advisors/Supervisors............................ 1,480 1 1 1,480
Recommenders.................................... 4,950 1 30/60 2,475
Financial Institutions.......................... 100 1 15/60 25
---------------------------------------------------------------
Subtotal.................................... 8,180 .............. .............. 22,130
Intramural LRPs
Renewal Applicants.............................. 40 1 7 280
Advisors/Supervisors............................ 40 1 2 80
Subtotal.................................... 80 .............. .............. 360
Extramural LRPS
Renewal Applicants.............................. 1,000 1 8 8,000
Advisors/Supervisors............................ 750 1 1 750
Recommenders.................................... 3,000 1 30/60 1,500
---------------------------------------------------------------
Subtotal.................................... 4,750 .............. .............. 10,250
Total................................... 13,218 .............. .............. 33,242
----------------------------------------------------------------------------------------------------------------
Dated: July 1, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2016-16227 Filed 7-7-16; 8:45 am]
BILLING CODE 4140-01-P
